NCT01095991View on ClinicalTrials.gov

Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

AZD1656

Oral tablet bd,

DRUG

Sitagliptin

Oral tablet od

Trial Locations (1)

Unknown

Research Site, Neuss

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT01095991 - Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter